Advanced Solid Tumors: INP12 Treatment

We are evaluating the safety and how the body handles a new treatment called INP12 in patients with advanced solid tumors. This study aims to understand if INP12 is safe for further testing.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Vall D Hebron Institute Of Oncology
Oncology
Alboraya, Spain
Hospital Universitario De Navarra
Oncology
Barañáin, Spain
Sponsor: Innoup Farma S.L.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.